CHM said the following,
”..although one participant experienced a serious adverse event of grade 3 cerebral edema, possibly attributed to CAR T cells.”
“However, at subcellular resolution, surface binding of CLTX was related to, but not precisely overlapping, with MMP-2 or other putative receptors.”
“However, the precise composition and structure of the cell surface complex recognized by CLTX-CAR T cells remains an unresolved question of increasing importance.”
But nothing to discuss and the share price fall is driven by idiots?
- Forums
- ASX - By Stock
- Ann: CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

CHM said the following,”..although one participant experienced a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $20.21K | 5.053M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2213046 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 13563373 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2213046 | 0.004 |
41 | 25878271 | 0.003 |
16 | 14950505 | 0.002 |
11 | 53600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 13563373 | 20 |
0.006 | 13884684 | 16 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 15.01pm 24/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |